Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Sumitomo Dainippon

VR/AR Applications for Training and Healthcare

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)...

Impetus Digital

- PMLiVE

Mergers and acquisitions: agents for change

Getting the best from your agency in a disruptive time

Bedrock Healthcare Communications

- PMLiVE

A snapshot of Congenica

PME talks to CEO David Atkins

- PMLiVE

EU, US biotechs merge to create fibrosis, cancer player

New company will be headquartered in Copenhagen, Denmark

- PMLiVE

Merck buys ArQule for $2.7bn in another cancer bolt-on deal

Deal due to close in the first quarter of 2020

- PMLiVE

Germany’s Vivoryon raises €43m for Alzheimer’s drug trial

Results of European study expected in 2022

- PMLiVE

Building European biotech firms to rival those of the US

PME speaks to Richard Mason on how drug discovery is evolving

- PMLiVE

HealthCare21 experience the Lucid magic at its Engagement Day

Yesterday was a big step forward in the integration of HealthCare21 into Lucid Group.  Everyone from the HealthCare21 team attended the Engagement Day at Quarry House Mill, Macclesfield.The aim was to...

Lucid Group Communications Limited

- PMLiVE

Innate Pharma and AstraZeneca take monalizumab into phase 3

AZ hopes to catch up to rivals using the French biotech's candidate

- PMLiVE

Acceleron scraps rare muscular dystrophy drug

Clinical profile not strong enough to push into late-stage testing

- PMLiVE

Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21

Lucid Group is delighted to announce its latest acquisition, welcoming colleagues from Healthcare consultancy HealthCare21 into its magic kingdom.Over the last twelve years, Lucid Group has become well known and...

Lucid Group Communications Limited

- PMLiVE

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Could acquire up to 11 Roivant spinouts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links